Search research articles
Contact Us
Filters
Showing results (71-80 of 117) with videos related to
Page
of 12
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2015
Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
Antoine Tanne, Luciana R Muniz, Anna Puzio-Kuter, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Nature Immunology
|
February 5, 2025
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Stanislav Dikiy, Aazam P Ghelani, Andrew G Levine, et al.
Cancer Research
|
June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones
Mariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Nature Communications
|
March 25, 2025
Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Nature Communications
|
February 28, 2025
Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Ebiomedicine
|
December 10, 2025
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 117) with videos related to
Sort By:
Page
of 12
Proceedings of the National Academy of Sciences of the United States of America
|
November 18, 2015
Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
Antoine Tanne, Luciana R Muniz, Anna Puzio-Kuter, et al.
Nature
|
November 14, 2017
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov, et al.
Nature Communications
|
July 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector
Nicholas Ceglia, Zachary Sethna, Samuel S Freeman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 29, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination
James W Smithy, Victoria Ciallella, Claire Thant, et al.
Nature Immunology
|
February 5, 2025
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Stanislav Dikiy, Aazam P Ghelani, Andrew G Levine, et al.
Cancer Research
|
June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones
Mariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Nature Communications
|
March 25, 2025
Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Nature Communications
|
February 28, 2025
Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Ebiomedicine
|
December 10, 2025
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher, et al.
Page
of 12